Page: Company Financials
Contineum Therapeutics, Inc. Class A Common Stock
$11.84
+0.11 (0.94%)
As of: 2026-01-15
Master Data Export
Enterprise Value
| Metric | MRQ | MRQ-1 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Stock Price | 11.75 | 3.97 | 7.57 | 17.55 | 15.40 |
| Market Capitalization | 330.36M | 102.81M | 204.58M | 451.89M | 392.72M |
| (-) Cash & Equivalents | 42.63M | 20.78M | 28.63M | 39.08M | -3.55M |
| (+) Total Debt | 5.49M | 5.75M | 5.75M | 50.17M | 48.58M |
| Enterprise Value | 293.22M | 87.77M | 181.70M | 462.98M | 444.84M |
Income Statement
| Metric | TTM | TTM-1 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 0M | 0M | 0M | 50M | 0M | 0M |
| Cost of Revenue | 0M | 0M | 0M | 0M | 0M | 0M |
| Gross Profit | 0M | 0M | 0M | 50M | 0M | 0M |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 100.0% | 0.0% | 0.0% |
| R&D Expenses | 52M | 33M | 38M | 28M | 17M | 22M |
| SG&A Expenses | 16M | 10M | 12M | 6M | 5M | 6M |
| Operating Expenses | -34M | 44M | 51M | 66M | 22M | 29M |
| Operating Income (EBIT) | 34M | -44M | -51M | -16M | -23M | -29M |
| Operating Income Margin | 0.0% | 0.0% | 0.0% | -32.2% | 0.0% | 0.0% |
| Interest Income | 9M | 8M | 9M | 5M | 1M | 0M |
| Interest Expense | 0M | 0M | 0M | 0M | 0M | 0M |
| Net Interest Income | 9M | 8M | 9M | 4M | 0M | 0M |
| Unusual Items | -102M | 0M | 0M | 35M | -2M | 0M |
| EBT Excluding Unusual Items | 43M | -35M | -42M | -12M | -22M | -29M |
| Pre-Tax Income | -59M | -36M | -42M | 23M | -24M | -29M |
| Pre-Tax Margin | 0.0% | 0.0% | 0.0% | 46.3% | 0.0% | 0.0% |
| Income Tax Expense | 0M | 0M | 0M | 0M | 0M | 0M |
| Net Income | -59M | -35M | -42M | 23M | -24M | -29M |
| Net Income Margin | 0.0% | 0.0% | 0.0% | 45.4% | 0.0% | 0.0% |
| Depreciation & Amortization | 0M | 0M | 0M | 0M | 0M | 0M |
| EBITDA | 34M | -43M | -51M | -16M | -22M | -28M |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -31.8% | 0.0% | 0.0% |
| NOPAT | 27M | -34M | -40M | -16M | -18M | -23M |
| NOPAT Margin | 0.0% | 0.0% | 0.0% | -31.5% | 0.0% | 0.0% |
| Owner's Earnings | -59M | -36M | -43M | 23M | -24M | -29M |
| Owner's Earnings Margin | 0.0% | 0.0% | 0.0% | 45.0% | 0.0% | 0.0% |
| EPS (Basic) | -2.34 | -1.39 | -2.18 | 0.90 | -0.97 | -1.15 |
| EPS (Diluted) | -2.25 | -1.39 | -2.18 | 0.90 | -0.97 | -1.15 |
| Shares (Basic) | 26M | 26M | 19M | 25M | 25M | 25M |
| Shares (Diluted) | 26M | 26M | 19M | 25M | 25M | 25M |
Balance Sheet
| Metric | MRQ | MRQ-1 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | 42.63M | 20.78M | 21.94M | 15.53M | 5.57M | 4.63M |
| Short-Term Investments | 139.77M | 154.70M | 182.82M | 109.66M | 41.67M | 64.37M |
| Cash & Short-Term Investments | 182.41M | 175.48M | 204.76M | 125.19M | 47.24M | 69.00M |
| Net Receivables | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Inventory | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Other Current Assets | 2.52M | 1.36M | 1.63M | 2.52M | 1.15M | 0.78M |
| Total Current Assets | 184.93M | 176.84M | 206.39M | 127.71M | 48.39M | 69.78M |
| Property, Plant & Equipment | 5.65M | 5.86M | 6.46M | 1.40M | 2.12M | 0.64M |
| Goodwill | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Intangible Assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Long-Term Investments | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax Assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Other Non-Current Assets | 0.27M | 0.19M | 0.00M | 1.28M | 0.13M | 0.10M |
| Other Assets | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total Non-Current Assets | 5.92M | 6.05M | 6.46M | 2.68M | 2.24M | 0.74M |
| Total Assets | 190.85M | 182.89M | 212.85M | 130.39M | 50.64M | 70.52M |
| Accounts Payable | 0.79M | 2.00M | 1.81M | 0.64M | 0.43M | 0.66M |
| Short-Term Debt | 1.48M | 1.47M | 1.45M | 0.46M | 5.06M | 1.25M |
| Tax Payables | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Deferred Revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Other Current Liabilities | 4.10M | 3.75M | 6.71M | 4.39M | 2.06M | 1.76M |
| Total Current Liabilities | 6.36M | 7.21M | 9.97M | 5.48M | 7.55M | 3.67M |
| Long-Term Debt | 4.02M | 4.28M | 4.81M | 192.73M | 0.79M | 3.66M |
| Capital Lease Obligations | 0.00M | 5.75M | 6.26M | 0.57M | 1.90M | 0.00M |
| Deferred Tax Liabilities | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Other Non-Current Liabilities | 0.00M | 0.00M | 0.00M | 0.11M | 3.03M | 1.60M |
| Total Non-Current Liabilities | 4.02M | 10.03M | 11.07M | 193.41M | 5.72M | 5.26M |
| Total Liabilities | 10.38M | 17.25M | 21.04M | 198.89M | 13.27M | 8.93M |
| Preferred Stock | 0.00M | 0.00M | 0.00M | 0.00M | 132.48M | 132.48M |
| Common Stock | 0.03M | 0.03M | 0.03M | 0.00M | 0.01M | 0.01M |
| Retained Earnings | -162.22M | -149.43M | -117.40M | -75.14M | -97.86M | -73.61M |
| Accumulated OCI | 0.27M | 0.15M | 0.07M | 0.11M | -0.08M | -0.04M |
| Minority Interest | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total Shareholders’ Equity | -161.93M | -149.26M | -117.31M | -75.03M | 34.55M | 58.85M |
| Total Equity | -161.93M | -149.26M | -117.31M | -75.03M | 34.55M | 58.85M |
| Total Liabilities & Equity | -151.55M | -132.01M | -96.27M | 123.86M | 47.82M | 67.78M |
| Tangible Assets | 190.85M | 182.89M | 212.85M | 130.39M | 50.64M | 70.52M |
| Tangible Equity | -161.93M | -149.26M | -117.31M | -75.03M | 34.55M | 58.85M |
| Tangible Book Value | -161.93M | -149.26M | -117.31M | -75.03M | 34.55M | 58.85M |
| Total Investments | 139.77M | 154.70M | 182.82M | 109.66M | 41.67M | 64.37M |
| Net Debt | -37.14M | -15.03M | -15.68M | 177.67M | 0.28M | 0.28M |
Capital Metrics
| Metric | MRQ | MRQ-1 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Working Capital | 178.6M | 169.6M | 196.4M | 122.2M | 40.8M | 66.1M |
| Total Capital | 186.0M | 177.1M | 204.3M | 125.3M | 45.1M | 66.5M |
| Capital Employed | 184.5M | 175.7M | 202.9M | 124.9M | 43.1M | 66.8M |
| Invested Capital | 143.3M | 156.4M | 182.4M | 109.7M | 39.6M | 61.9M |
Cash Flow Statement
| Metric | TTM | TTM-1 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Net Income | -59.39M | -35.46M | -42.26M | 22.72M | -24.25M | -29.00M |
| Depreciation & Amortization | 0.31M | 0.22M | 0.26M | 0.20M | 0.33M | 0.33M |
| Deferred Income Tax | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Stock-Based Compensation | 7.56M | 0.76M | 6.80M | 2.22M | 1.93M | 1.75M |
| Change in Working Capital | -2.36M | -0.41M | 5.33M | -1.02M | -1.27M | 0.11M |
| Accounts Receivable | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Inventory | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Accounts Payable | -0.65M | 0.14M | 1.14M | 0.00M | -0.23M | -0.11M |
| Other Working Capital | -1.71M | -0.54M | 4.19M | -1.02M | -1.04M | 0.22M |
| Other Non-Cash Items | 1.40M | 1.54M | -2.98M | -4.76M | 3.14M | 0.55M |
| Net Cash from Operating Activities | -52.47M | -33.35M | -32.85M | 19.35M | -20.12M | -26.27M |
| Capital Expenditures (PPE) | -0.36M | -0.66M | -0.51M | -0.41M | -0.12M | -0.17M |
| Acquisitions (Net) | 0.00M | 0.02M | 0.02M | 0.00M | 0.00M | 0.00M |
| Purchases of Investments | -132.12M | -194.05M | -226.41M | -141.87M | -64.70M | -66.78M |
| Sales / Maturities of Investments | 166.83M | 143.37M | 157.16M | 76.71M | 87.12M | 1.98M |
| Other Investing Activities | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net Cash from Investing Activities | 34.35M | -51.32M | -69.74M | -65.57M | 22.30M | -64.97M |
| Net Debt Issuance | 0.00M | 0.00M | 0.00M | -3.75M | -1.25M | 0.00M |
| Long-Term Debt Issuance | 0.00M | 0.00M | 0.00M | 0.00M | -1.25M | 0.00M |
| Short-Term Debt Issuance | 0.00M | 0.00M | 0.00M | -3.75M | 0.00M | 0.00M |
| Net Stock Issuance | 19.92M | 108.36M | 108.21M | 60.11M | 0.00M | 79.73M |
| Common Stock Issuance | 19.92M | 108.36M | 108.21M | 0.00M | 0.00M | 0.00M |
| Common Stock Repurchased | 0.00M | 0.00M | 0.00M | -0.03M | 0.00M | 0.00M |
| Preferred Stock Issuance | 0.00M | 0.00M | 0.00M | 60.14M | 0.00M | 79.73M |
| Net Dividends Paid | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Common Dividends Paid | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Preferred Dividends Paid | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Other Financing Activities | -0.06M | -0.32M | 0.79M | -0.18M | 0.02M | 0.11M |
| Net Cash from Financing Activities | 19.86M | 108.04M | 109.00M | 56.18M | -1.24M | 79.84M |
| Effect of FX on Cash | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Net Change in Cash | 1.74M | 23.37M | 6.42M | 9.96M | 0.94M | -11.40M |
| Cash at Beginning of Period | 106.09M | 126.54M | 15.53M | 5.57M | 4.63M | 16.03M |
| Cash at End of Period | 107.83M | 149.91M | 21.94M | 15.53M | 5.57M | 4.63M |
| Operating Cash Flow | -52.47M | -33.35M | -32.85M | 19.35M | -20.12M | -26.27M |
| Capital Expenditure | -0.36M | -0.66M | -0.51M | -0.41M | -0.12M | -0.17M |
| Free Cash Flow | -52.83M | -34.00M | -33.36M | 18.94M | -20.24M | -26.43M |
Free Cash Flow
| Metric | TTM | TTM-1 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| EBITDA | -67.68M | -43.30M | -50.64M | 16.27M | -22.39M | -28.32M |
| (-) Tax Adjustment | 0.00M | -0.20M | 0.00M | 0.32M | 0.00M | 0.00M |
| (-) Change In Working Capital | -2.36M | -0.41M | 5.33M | -1.02M | -1.27M | 0.11M |
| (-) Capital Expenditure | -0.36M | -0.66M | -0.51M | -0.41M | -0.12M | -0.17M |
| Unlevered Free Cash Flow | -65.68M | -43.36M | -56.48M | 16.57M | -21.24M | -28.60M |
| (-) Net Interest Income After Taxes | 8.76M | 8.13M | 8.91M | 4.31M | 0.37M | -0.26M |
| Net Debt Issuance | 0.00M | 0.00M | 0.00M | -3.75M | -1.25M | 0.00M |
| Levered Free Cash Flow | -74.44M | -51.49M | -65.39M | 8.50M | -22.87M | -28.34M |